HUMA PEER ANALYSIS

Humacyte Inc — metric-by-metric comparison with peers and the industry median

HUMAHumacyte Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

HUMAIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	HUMA	RTALB	MSB	TLX	Ind. Median
P/E	—	4.78	—	—	18.06
P/B	13.12	0.59●	—	6.38	3.62
EV/EBITDA	—	72.98●	—	120.20	15.13
P/S	75.65	6.52	31.30	3.24●	10.65

Financial Health
Metric	HUMA	RTALB	MSB	TLX	Ind. Median
Current Ratio	3.93●	1.21	—	1.43	5.90
Debt/Equity	566.9%	1.2%●	—	112.3%	10.9%
NetDebt/EBITDA	-0.22●	0.90	—	13.13	1.15

Profitability
Metric	HUMA	RTALB	MSB	TLX	Ind. Median
Net Margin	-4,840.8%	136.3%●	-115.3%	-0.9%	-125.7%
ROE	-409.5%	15.1%●	-11.3%	-1.8%	-47.5%
ROA	-71.5%	13.1%●	-8.6%	-0.7%	-35.8%
EBITDA Margin	-3,956.7%	9.0%●	-76.6%	3.0%	-105.8%

Growth + Dividend
Metric	HUMA	RTALB	MSB	TLX	Ind. Median
Rev. Growth	-74.0%	24.0%	410.4%●	56.3%	5.1%
NI Growth	—	134.0%	—	—	12.1%
Div. Yield	0.0%●	0.0%●	0.0%●	—	0.2%
Payout	0.0%	0.0%	0.0%	—	0.0%

Valuation
Metric	HUMA	ALDX	CUE	AGEN	OBIO	TNYA	Ind. Median
P/E	—	—	—	2.07	—	—	18.06
P/B	13.12	3.19	7.43	-0.61●	2.98	1.33	3.62
EV/EBITDA	—	—	—	3.18	—	—	15.13
P/S	75.65	—	4.90	1.08●	4.65	625.48	10.65

Financial Health
Metric	HUMA	ALDX	CUE	AGEN	OBIO	TNYA	Ind. Median
Current Ratio	3.93	2.72	3.57	0.38	7.03●	5.75	5.90
Debt/Equity	566.9%	36.8%	15.9%	-137.6%●	66.0%	9.5%	10.9%
NetDebt/EBITDA	-0.22●	1.96	0.82	2.12	1.15	0.94	1.15

Profitability
Metric	HUMA	ALDX	CUE	AGEN	OBIO	TNYA	Ind. Median
Net Margin	-4,840.8%	—	-59.6%	52.2%●	-167.0%	-36,891.1%	-125.7%
ROE	-409.5%	-51.8%●	-138.5%	—	-161.1%	-73.6%	-47.5%
ROA	-71.5%	-34.3%	-73.5%	33.4%●	-68.4%	-59.5%	-35.8%
EBITDA Margin	-3,956.7%	—	-48.4%	102.6%●	-161.1%	-33,540.9%	-105.8%

Growth + Dividend
Metric	HUMA	ALDX	CUE	AGEN	OBIO	TNYA	Ind. Median
Rev. Growth	-74.0%	-100.0%	309.6%	24.5%	1,033.9%●	—	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	0.0%	—	—	—	—	—	0.2%
Payout	0.0%	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on HUMA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.